AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Goncz, KK Colosimo, A Dallapiccola, B Gagne, L Hong, K Novelli, G Papahadjopoulos, D Sawa, T Schreier, H Wiener-Kronish, J Xu, Z Gruenert, DC
Citation: Kk. Goncz et al., Expression of Delta F508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR, GENE THER, 8(12), 2001, pp. 961-965

Authors: Park, JW Kirpotin, DB Hong, K Shalaby, R Shao, Y Nielsen, UB Marks, JD Papahadjopoulos, D Benz, CC
Citation: Jw. Park et al., Tumor targeting using anti-her2 immunoliposomes, J CONTR REL, 74(1-3), 2001, pp. 95-113

Authors: Petrikovics, I Cheng, TC Papahadjopoulos, D Hong, K Yin, R DeFrank, JJ Jaing, J Song, ZH McGuinn, WD Sylvester, D Pei, L Madec, J Tamulinas, C Jaszbetenyi, JC Barcza, T Way, JL
Citation: I. Petrikovics et al., Long ciuculating liposomes encapsulating organophosphorus acid anhydrolasein diisopropylfluorophosphate antagonism, TOXICOL SCI, 57(1), 2000, pp. 16-21

Authors: Petrikovics, I Hong, K Omburo, G Hu, QZ Pei, L McGuinn, WD Sylvester, D Tamulinas, C Papahadjopoulos, D Jaszberenyi, JC Way, JL
Citation: I. Petrikovics et al., Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes, TOX APPL PH, 156(1), 1999, pp. 56-63

Authors: Drummond, DC Meyer, O Hong, KL Kirpotin, DB Papahadjopoulos, D
Citation: Dc. Drummond et al., Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, PHARM REV, 51(4), 1999, pp. 691-743

Authors: Park, JW Kirpotin, D Hong, K Colbern, G Shalaby, R Shao, Y Meyer, O Nielsen, U Marks, J Benz, CC Papahadjopoulos, D
Citation: Jw. Park et al., Anti-HER2 immunoliposomes for targeted drug delivery, MED CHEM RE, 8(7-8), 1998, pp. 383-391

Authors: Papahadjopoulos, D Kirpotin, DB Park, JW Hong, KL Shao, Y Shalaby, R Colbern, G Benz, CC
Citation: D. Papahadjopoulos et al., Targeting of drugs to solid tumors using anti-HER2 immunoliposomes, J LIPOS RES, 8(4), 1998, pp. 425-442

Authors: Lasic, DD Papahadjopoulos, D
Citation: Dd. Lasic et D. Papahadjopoulos, General introduction, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 1-7

Authors: Lasic, DD Papahadjopoulos, D
Citation: Dd. Lasic et D. Papahadjopoulos, Cancer therapy, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 221-230

Authors: Kirpotin, DB Park, JW Hong, KL Shao, Y Colbern, G Zheng, WW Meyer, O Benz, CC Papahadjopoulos, D
Citation: Db. Kirpotin et al., Targeting of sterically stabilized liposomes to cancers overexpressing HER2/neu proto-oncogene, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 325-345

Authors: Nicolau, C Papahadjopoulos, D
Citation: C. Nicolau et D. Papahadjopoulos, Gene therapy: Liposomes and gene delivery - a perspective, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 347-352

Authors: Lasic, DD Papahadjopoulos, D
Citation: Dd. Lasic et D. Papahadjopoulos, Other applications, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 451-453

Authors: Papahadjopoulos, D Lasic, DD
Citation: D. Papahadjopoulos et Dd. Lasic, Future of liposome applications: Serendipity vs. design, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. 751-754

Authors: Lasic, DD Papahadjopoulos, D
Citation: Dd. Lasic et D. Papahadjopoulos, Medical applications of liposomes - Foreword, MEDICAL APPLICATIONS OF LIPOSOMES, 1998, pp. VII-IX
Risultati: 1-14 |